(S (NP (DT An) (NN ability) (S (VP (TO to) (VP (VB map) (NP (NP (ADJP (NN seizure) (HYPH -) (VBG generating)) (NN brain) (NN tissue)) (, ,) (ADVP (FW i.e.)) (, ,) (NP (DT the) (NN seizure) (NN onset) (NN zone) (PRN (-LRB- -LRB-) (NP (NN SOZ)) (-RRB- -RRB-))) (, ,) (PP (IN without) (NP (VBG recording) (JJ actual) (NNS seizures)))))))) (VP (MD could) (VP (VB reduce) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ invasive) (NN EEG) (NN monitoring)))) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (NN drug) (HYPH -) (JJ resistant)) (NN epilepsy))))))) (. .))
(S (NP (NP (DT A) (ADJP (RB widely) (HYPH -) (VBN adopted)) (NN practice)) (PP (IN in) (NP (DT the) (NN literature)))) (VP (VBZ is) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN incidence)) (SBAR (S (NP (NP (-LRB- -LRB-) (NP (NNS events)) (, /) (NP (NN time)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (JJ putative) (JJ pathological) (JJ electrophysiological) (NNS biomarkers)) (VP (VBN associated) (PP (IN with) (NP (JJ epileptic) (NN brain) (NN tissue))) (PP (IN with) (NP (DT the) (NNP SOZ))))))) (VP (VBD determined) (PP (IN from) (NP (NP (JJ spontaneous) (NNS seizures)) (VP (VBN recorded) (PP (IN with) (NP (JJ intracranial) (NN EEG))) (, ,) (S (ADVP (RB primarily)) (VP (VBG using) (NP (DT a) (JJ single) (NN biomarker))))))))))))))) (. .))
(S (NP (NP (JJ Clinical) (NN translation)) (PP (IN of) (NP (DT the) (JJ previous) (NNS efforts)))) (VP (VBZ suffers) (PP (IN from) (NP (PRP$ their) (NN inability) (S (VP (TO to) (VP (VB generalize) (PP (IN across) (NP (JJ multiple) (NNS patients))) (PP (IN because) (PP (IN of) (NP (NP (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-)) (NP (DT the) (JJ inter-patient) (NN variability))) (CC and) (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (DT the) (JJ temporal) (NN variability)) (PP (IN in) (NP (DT the) (JJ epileptogenic) (NN activity))))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP report) (NP (NP (DT an) (ADJP (NP (JJ artificial) (NN intelligence)) (HYPH -) (VBN based)) (NN approach)) (PP (IN for) (S (VP (VBG combining) (NP (NP (JJ multiple) (JJ interictal) (JJ electrophysiological) (NNS biomarkers)) (CC and) (NP (PRP$ their) (JJ temporal) (NNS characteristics))) (PP (IN as) (NP (NP (DT a) (NN way)) (PP (IN of) (NP (NP (NN accounting)) (PP (IN for) (NP (DT the) (JJ above) (NNS barriers)))))))))))) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (ADVP (RB reliably)) (VP (VB identify) (NP (NN seizure) (NN onset) (NNS zones)) (PP (IN in) (NP (NP (DT a) (NN study) (NN cohort)) (PP (IN of) (NP (NP (CD 82) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NN evaluation)) (PP (IN for) (NP (ADJP (NN drug) (HYPH -) (JJ resistant)) (NN epilepsy)))))))))))))))) (. .))
(S (NP (PRP$ Our) (NN investigation)) (VP (VBZ provides) (NP (NN evidence)) (SBAR (IN that) (S (S (VP (VBG utilizing) (NP (DT the) (JJ complementary) (NN information)) (PP (VBN provided) (PP (IN by) (NP (JJ multiple) (JJ electrophysiological) (NNS biomarkers)))))) (CC and) (PRN (S (NP (PRP$ their) (JJ temporal) (NNS characteristics)) (VP (MD can) (ADVP (RB significantly)) (VP (VB improve) (NP (DT the) (NN localization) (NN potential)) (PP (VBN compared) (PP (IN to) (NP (ADJP (RB previously) (VBN published)) (NML (JJ single) (HYPH -) (NN biomarker)) (ADJP (NP (NN incidence)) (HYPH -) (VBN based)) (NNS approaches))))))) (, ,)) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (JJ average) (NN area)) (PP (IN under) (NP (NP (NNP ROC) (NN curve) (-LRB- -LRB-) (NN AUC) (-RRB- -RRB-) (NN value)) (PP (IN of) (NP (CD 0.73))))))) (PP (IN in) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 82) (NNS patients)))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (VBG recording) (NNS durations)) (PP (IN between) (NP (NP (CD ninety) (NNS minutes)) (CC and) (NP (CD two) (NNS hours))))) (VP (VBP are) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB localize) (NP (NNS SOZs)) (PP (IN with) (NP (NP (NNS accuracies)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB prove) (ADJP (RB clinically) (JJ relevant)))))))))))))))) (. .))
(FRAG (NP (NP (DT The) (JJ successful) (NN validation)) (PP (IN of) (NP (NP (PRP$ our) (NN approach)) (PP (IN on) (NP (NP (DT a) (JJ large) (NN cohort)) (PP (IN of) (NP (CD 82) (NNS patients)))))))) (NP (NNS warrants)) (NP (JJ future) (NN investigation)) (PP (IN on) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG utilizing) (NP (NP (JJ intra-operative) (NN EEG) (NN monitoring)) (CC and) (NP (JJ artificial) (NN intelligence))) (S (VP (TO to) (VP (VB localize) (NP (JJ epileptogenic) (NN brain) (NN tissue)))))))))) (. .))
